TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

Videos | October 11, 2018
Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific,...
Videos | October 11, 2018
A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president,...
The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks FFRangio angiography imaging derived fractional flow reserve (FFR-angio) technology matched the performance of wire-based FFR measurements. #TCT2018

The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks FFRangio angiography imaging derived fractional flow reserve (FFR-angio) technology matched the performance of wire-based FFR measurements.

News | FFR Technologies | October 04, 2018
October 4, 2018 — The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks...
 Pulmonary artery denervation for CpcPH from the PADN-5 trial. #TCT2017

A series of procedural images of a pulmonary artery denervation for CpcPH from the PADN-5 trial.

News | Hypertension | October 04, 2018
October 4, 2018 — Pulmonary artery denervation (PADN) is associated with significant improvements in hemodynamic and...
Biomodex Announces New Training Solution for Left Atrial Appendage Closure
Technology | Medical 3-D Printing | October 04, 2018
October 4, 2018 — Three-dimensional printing company Biomodex, which develops organ twins for advanced physician...
The Biotronik Osiro is an ultra thin strut, sirolimus-eluting stent. #TCT2018

The Biotronik Osiro is an ultra thin strut, sirolimus-eluting stent.

News | Stents | October 04, 2018
October 4, 2018 – Investigators unveiled clinical data from the independent BIONYX and SORT OUT IX all-comers trials...
Videos | TCT | October 03, 2018
DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technology he found on the expo...
Prosthetic Valve Mismatches Common in TAVR Procedures
News | Heart Valve Technology | October 03, 2018
October 3, 2018 — A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR)...
BackBeat Cardiac Neuromodulation Therapy Reduces Blood Pressure at Two Years
News | Hypertension | October 02, 2018
October 2, 2018 — Two-year results of the Moderato I Study demonstrated immediate, substantial and sustained reduction...
IVUS-Guided Drug-Eluting Stent Implantation Improves Clinical Outcomes in All-Comer Patients
News | Intra-Vascular Ultrasound (IVUS) | October 02, 2018
October 2, 2018 — Intravascular ultrasound (IVUS) guidance improved clinical outcomes over angiography guidance during...
Videos | Womens Cardiovascular Health | October 01, 2018
Cindy Grines, M.D., chair and professor, department of cardiology, Zucker School of Medicine, Hostra/Northwell, spoke...
Videos | Left Atrial Appendage (LAA) Occluders | October 01, 2018
Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix,...
Resolute Onyx Stent With Improved Radiographic Visibility Found to Be Safe and Effective
News | Stents Drug Eluting | October 01, 2018
October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer-...
Boston Scientific Receives FDA Approval for Eluvia Drug-Eluting Vascular Stent
Technology | Stents Drug Eluting | October 01, 2018
October 1, 2018 — Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its...
Magnitude Bioresorbable Scaffold Shows Low MACE, Restenosis Rates at Nine Months
News | Stents Bioresorbable | October 01, 2018
October 1, 2018 — New results from the RENASCENT studies presented at the Transcatheter Cardiovascular Therapeutics (...